124 related articles for article (PubMed ID: 6351106)
1. The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials.
Lloyd KG; Morselli PL; Depoortere H; Fournier V; Zivkovic B; Scatton B; Broekkamp C; Worms P; Bartholini G
Pharmacol Biochem Behav; 1983 Jun; 18(6):957-66. PubMed ID: 6351106
[TBL] [Abstract][Full Text] [Related]
2. [Implications of GABAergic synapses in neuropsychiatry].
Lloyd KG; Perrault G; Zivkovic B
J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
4. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
Bartholini G
Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
[TBL] [Abstract][Full Text] [Related]
5. GABA receptor agonists: pharmacological spectrum and therapeutic actions.
Bartholini G
Med Res Rev; 1985; 5(1):55-75. PubMed ID: 2984490
[TBL] [Abstract][Full Text] [Related]
6. Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region.
Bovier P; Broekkamp CL; Lloyd KG
Brain Res; 1982 Sep; 248(2):313-20. PubMed ID: 6128055
[TBL] [Abstract][Full Text] [Related]
7. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
8. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
Lloyd KG; Arbilla S; Beaumont K; Briley M; De Montis G; Scatton B; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):672-7. PubMed ID: 6121050
[TBL] [Abstract][Full Text] [Related]
9. Comparison of progabide with other antiepileptic and GABAergic drugs.
Fromm GH; Terrence CF; Chattha AS
Epilepsia; 1985; 26(6):672-81. PubMed ID: 3000759
[TBL] [Abstract][Full Text] [Related]
10. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
Morselli PL; Fournier V; Bossi L; Musch B
Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
[TBL] [Abstract][Full Text] [Related]
11. Action of progabide in the photosensitive baboon, Papio papio.
Cepeda C; Worms P; Lloyd KG; Naquet R
Epilepsia; 1982 Oct; 23(5):463-70. PubMed ID: 7140662
[TBL] [Abstract][Full Text] [Related]
12. Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy.
Green AR; Johnson P; Mountford JA; Nimgaonkar VL
Br J Pharmacol; 1985 Feb; 84(2):337-46. PubMed ID: 2983809
[TBL] [Abstract][Full Text] [Related]
13. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
[TBL] [Abstract][Full Text] [Related]
14. Progabide, a GABA mimetic drug, stimulates the secretion of plasma corticosterone in rats.
Manev H; Pericić D
Pharmacol Biochem Behav; 1987 Dec; 28(4):443-6. PubMed ID: 3432311
[TBL] [Abstract][Full Text] [Related]
15. Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disorders.
Lloyd KG; Munari C; Worms P; Bossi L; Morselli PL
Prog Clin Biol Res; 1983; 124():285-97. PubMed ID: 6410408
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
[TBL] [Abstract][Full Text] [Related]
17. Interactions between dopamine and GABA in the control of ambulatory activity and neophobia in the mouse.
Agmo A; Belzung C
Pharmacol Biochem Behav; 1998 Jan; 59(1):239-47. PubMed ID: 9443561
[TBL] [Abstract][Full Text] [Related]
18. Progabide for refractory partial epilepsy: a controlled add-on trial.
Schmidt D; Utech K
Neurology; 1986 Feb; 36(2):217-21. PubMed ID: 3511402
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and therapeutic actions of GABA receptor agonists.
Zivkovic B; Scatton B; Worms P; Lloyd KG; Bartholini G
J Neural Transm Suppl; 1983; 18():319-26. PubMed ID: 6308150
[TBL] [Abstract][Full Text] [Related]
20. Effect of GABA agonists on the neurotoxicity and anticonvulsant activity of benzodiazepines.
Chweh AY; Swinyard EA; Wolf HH; Kupferberg HJ
Life Sci; 1985 Feb; 36(8):737-44. PubMed ID: 2983169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
